Arden “Mini” Fragrance Open Sell Initiative Aims For Maxi Mass Market Gains
This article was originally published in The Rose Sheet
Executive Summary
Elizabeth Arden mass market revenue advanced 13% in Q2 on the strength of the firm's open sell miniature fragrance initiative in chain drug retail accounts, CEO Scott Beattie reported during a Sept. 4 earnings call